In a population-based cohort of diabetes patients, men and women had similar risks for all-cause mortality

Journal of Clinical Epidemiology

Volumn 60, Issue 1, 2007, Pages 86-93

  Shalev, Varda ^a   Chodick, Gabriel ^a,b   Bialik, Martin ^a   Green, Manfred S ^b   Heymann, Anthony D ^a,b  

^a MACCABI HEALTHCARE SERVICES   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

ACE inhibitors; Cholesterol; Creatinine; Diabetes; Dialysis; Gender; Glycated hemoglobin; Insulin; Israel; Mortality

Indexed keywords

CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HIGH DENSITY LIPOPROTEIN; INSULIN; LOW DENSITY LIPOPROTEIN;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETIC PATIENT; DIALYSIS; FEMALE; FOLLOW UP; HEALTH CARE ORGANIZATION; HUMAN; ISRAEL; MAJOR CLINICAL STUDY; MALE; MORTALITY; POPULATION RESEARCH; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SURVIVAL;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BIOLOGICAL MARKERS; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CREATININE; DIABETES MELLITUS; DRUG UTILIZATION; EPIDEMIOLOGIC METHODS; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; ISRAEL; MALE; MARITAL STATUS; MIDDLE AGED; PROGNOSIS; RENAL DIALYSIS; SEX DISTRIBUTION; SEX FACTORS;

EID: 33845224953     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jclinepi.2006.04.010     Document Type: Article

References (51)

1. Boyle J., Honeycutt A., Narayan K., Hoerger T., Geiss L., Chen H., et al. Projection of diabetes burden through 2050: impact of changing demography and disease prevalence in the U.S. Diabetes Care 24 (2001) 1936-1940
2. Chodick G., Heymann A., Shalev V., and Kookia E. The epidemiology of diabetes in a large Israeli HMO. Eur J Epidemiol 18 (2003) 1143-1146
3. Rennert G., and Peterburg Y. Prevalence of selected chronic diseases in Israel. Isr Med Assoc J 3 (2001) 404-408
4. Gatling W., Tufail S., Mullee M., Westacott T., and Hill R. Mortality rates in diabetic patients from a community-based population compared to local age/sex matched controls. Diabet Med 14 (1997) 316-320
5. Morgan C., Currie C., and Peters J. Relationship between diabetes and mortality: a population study using record linkage. Diabetes Care 23 (2000) 1103-1107
6. Chan J., Cheung C., Cheung M., Swaminathan R., Critchley J., and Cockram C. Abnormal albuminuria as a predictor of mortality and renal impairment in Chinese patients with NIDDM. Diabetes Care 18 (1995) 1013-1016
7. Gall M., Borch-Johnsen K., Hougaard P., Nielsen F., and Parving H. Albuminuria and poor glycemic control predict mortality in NIDDM. Diabetes 44 (1995) 1303-1309
8. Mattock M., Barnes D., Viberti G., Keen H., Burt D., Hughes J., et al. Microalbuminuria and coronary heart disease in NIDDM: an incidence study. Diabetes 47 (1998) 1786-1792
9. Berger B., Stenstrom G., and Sundkvist G. Incidence, prevalence, and mortality of diabetes in a large population. A report from the Skaraborg Diabetes Registry. Diabetes Care 22 (1999) 773-778
10. Biderman A., Rosenblatt I., Rosen S., Zangwill L.M., Shalev R., Friger M., et al. Sex differentials in predictors of mortality for patients with adult-onset diabetes: a population-based follow-up study in Beer-Sheva, Israel. Diabetes Care 23 (2000) 602-605
11. Florkowski C., Scott R., Coope P., and Moir C. Predictors of mortality from type 2 diabetes mellitus in Canterbury, New Zealand; a ten-year cohort study. Diabetes Res Clin Pract 53 (2001) 113-120
12. Soedamah-Muthu S.S., Fuller J.H., Mulnier H.E., Raleigh V.S., Lawrenson R.A., and Colhoun H.M. All-cause mortality rates in patients with type 1 diabetes mellitus compared with a non-diabetic population from the UK general practice research database, 1992-1999. Diabetologia 49 (2006) 660-666
13. American Diabetes Association. Management of dyslipidemia in adults with diabetes. Diabetes Care 25 Suppl 1 (2002) S74-S77
14. Statistical abstract of Israel no. 56. Central Bureau of Statistics; 2005.
15. Wallach J. Interpretation of diagnostic tests. 7th edition (2000), Lippincott Williams & Wilkins, Philadelphia, PA
16. Hu G., and DECODE Study Group. Gender difference in all-cause and cardiovascular mortality related to hyperglycaemia and newly-diagnosed diabetes. Diabetologia 46 (2003) 608-617
17. Ostgren C., Lindblad U., Melander A., and Rastam L. Survival in patients with type 2 diabetes in a Swedish community: Skaraborg hypertension and diabetes project. Diabetes Care 25 (2002) 1297-1302
18. Hanninen J., Takala J., and Keinanen-Kiukaanniemi S. Albuminuria and other risk factors for mortality in patients with non-insulin-dependent diabetes mellitus aged under 65 years: a population-based prospective 5-year study. Diabetes Res Clin Pract 43 (1999) 121-126
19. Rossing P., Breum L., Major-Pedersen A., Sato A., Winding H., Pietersen A., et al. Prolonged QTc interval predicts mortality in patients with type 1 diabetes mellitus. Diabet Med 18 (2001) 199-205
20. Kanaya A., Grady D., and Barrett-Connor E. Explaining the sex difference in coronary heart disease mortality among patients with type 2 diabetes mellitus: a meta-analysis. Arch Intern Med 162 (2002) 1737-1745
21. Lee W., Cheung A., Cape D., and Zinman B. Impact of diabetes on coronary artery disease in women and men: a meta-analysis of prospective studies. Diabetes Care 23 (2000) 962-968
22. Shalev V., Chodick G., Heymann A., and Kokia E. Gender differences in healthcare utilization and medical indicators among patients with diabetes. Public Health 119 (2005) 45-49
23. Khaw K.T., Wareham N., Luben R., Bingham S., Oakes S., Welch A., et al. Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of European prospective investigation of cancer and nutrition (EPIC-Norfolk). BMJ 322 (2001) 15-18
24. Knuiman M., Welborn T., and Whittall D. An analysis of excess mortality rates for persons with non-insulin-dependent diabetes mellitus in Western Australia using the Cox proportional hazards regression model. Am J Epidemiol 135 (1992) 638-648
25. Ohkubo Y., Kishikawa H., Araki E., Miyata T., Isami S., Motoyoshi S., et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract 28 (1995) 103-117
26. UK Prospective Diabetes Study Group. Intensive blood glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352 (1998) 837-853
27. National Cholesterol Education Program. Detection, evaluation, and treatment of high blood cholesterol in adults. NIH Publication No. 02-5215. 2002. Available at http://www.nhlbi.nih.gov/guidelines/cholesterol/atp3full.pdf. (accessed Aug 2, 2006).
28. Vijan S., and Hayward R. Pharmacologic lipid-lowering therapy in type 2 diabetes mellitus: background paper for the American College of Physicians. Ann Intern Med 140 (2004) 650-658
29. Katakura M., Naka M., Kondo T., Nishii N., Komatsu M., Sato Y., et al. Prospective analysis of mortality, morbidity, and risk factors in elderly diabetic subjects: Nagano study. Diabetes Care 26 (2003) 638-644
30. Colhoun H., Betteridge D., Durrington P., Hitman G., Neil H., Livingstone S., et al. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial. Lancet (2004) 685-696
31. Fairclough D., Peterson H., and Chang V. Why are missing quality of life data a problem in clinical trials of cancer therapy?. Stat Med 17 (1998) 667-677
32. Engels J., and Diehr P. Imputation of missing longitudinal data: a comparison of methods. J Clin Epidemiol 56 (2003) 968-976
33. Hu F., Manson J., Stampfer M., Colditz G., Liu S., Solomon C., et al. Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N Engl J Med 345 (2001) 790-797
34. Byers T. Body weight and mortality. N Engl J Med 333 (1995) 723-724
35. Solomon C., and Manson J. Obesity and mortality: a review of the epidemiologic data. Am J Clin Nutr 66 4 Suppl (1997) 1044S-1050S
36. Israel Center for Disease Control. Health status in Israel 1999. Tel-Hashomer: Israel Ministry of Health; 1999. Report No. 209.
37. Health Survey 1996/97-advanced data for the period April-September, 1996. Jerusalem: Israel Central Bureau of Statistics; 1997. Report No. 39.
38. Abou-Rbiah Y., and Weitzman S. Diabetes among Bedouins in the Negev: the transition from a rare to a highly prevalent condition. Isr Med Assoc J 4 (2002) 687-689
39. Cohen A., Gefen K., Ozer A., Bagola N., Milrad V., Cohen L., et al. Diabetes control in the Bedouin population in Southern Israel. Med Sci Monit 11 (2005) CR376-CR380
40. Bloom J., and Spiegel D. The relationship of two dimensions of social support to the psychological well-being and social functioning of women with advanced breast cancer. Soc Sci Med 19 (1984) 831-837
41. Trief P., Himes C., Orendorff R., and Weinstock R. The marital relationship and psychosocial adaptation and glycemic control of individuals with diabetes. Diabetes Care 24 (2001) 1384-1389
42. Allawi J., Rao P., Gilbert R., Scott G., Jarrett R., Keen H., et al. Microalbuminuria in non-insulin-dependent diabetes: its prevalence in Indian compared with Europid patients. BMJ (Clin Res Ed) 296 (1988) 462-464
43. Gall M.A., Rossing P., Skott P., Damsbo P., Vaag A., Bech K., et al. Prevalence of micro- and macroalbuminuria, arterial hypertension, retinopathy and large vessel disease in European type 2 (non-insulin-dependent) diabetic patients. Diabetologia 34 (1991) 655-661
44. Gupta D., Verma L., Khosla P., and Dash S. The prevalence of microalbuminuria in diabetes: a study from north India. Diabetes Res Clin Pract 12 (1991) 125-128
45. Klein R., Klein B., and Moss S. Prevalence of microalbuminuria in older-onset diabetes. Diabetes Care 16 (1993) 1325-1330
46. Messent J., Elliott T., Hill R., Jarrett R., Keen H., and Viberti G. Prognostic significance of microalbuminuria in insulin-dependent diabetes mellitus: a twenty-three year follow-up study. Kidney Int 41 (1992) 836-839
47. Patrick A., Leslie P., Clarke B., and Frier B. The natural history and associations of microalbuminuria in type 2 diabetes during the first year after diagnosis. Diabet Med 7 (1990) 902-908
48. MacLeod J., Lutale J., and Marshall S. Albumin excretion and vascular deaths in NIDDM. Diabetologia 38 (1995) 610-616
49. Mattock M., Morrish N., Viberti G., Keen H., Fitzgerald A., and Jackson G. Prospective study of microalbuminuria as predictor of mortality in NIDDM. Diabetes 41 (1992) 736-741
50. Neil A., Hawkins M., Potok M., Thorogood M., Cohen D., and Mann J. A prospective population-based study of microalbuminuria as a predictor of mortality in NIDDM. Diabetes Care 16 (1993) 996-1003
51. Niskanen L., Penttila I., Parviainen M., and Uusitupa M. Evolution, risk factors, and prognostic implications of albuminuria in NIDDM. Diabetes Care 19 (1996) 486-493